|
|
|
Volumn 44, Issue 1146, 2002, Pages 107-109
|
|
Metaglip and Avandamet for type 2 diabetes.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDIABETIC AGENT;
GLIPIZIDE;
GLIPIZIDE PLUS METFORMIN;
METFORMIN;
ROSIGLITAZONE METFORMIN COMBINATION;
ROSIGLITAZONE-METFORMIN COMBINATION;
THIAZOLE DERIVATIVE;
ARTICLE;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG ADMINISTRATION;
DRUG COMBINATION;
FEE;
HUMAN;
NON INSULIN DEPENDENT DIABETES MELLITUS;
CLINICAL TRIALS;
DIABETES MELLITUS, TYPE 2;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
DRUG COMBINATIONS;
FEES, PHARMACEUTICAL;
GLIPIZIDE;
HUMANS;
HYPOGLYCEMIC AGENTS;
METFORMIN;
THIAZOLES;
|
|
EID: 0037164570
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (8)
|
|
References (0)
|